Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marı́a Sarasa-Nacenta"'
Autor:
Jerónimo Pachón, Eva León-Jimenez, Aristides Alarcón-González, Yolanda López-Púa, Rosa Ruiz-Valderas, Luis F. López-Cortés, Pompeyo Viciana, Jesús Gómez-Mateos, Marı́a Sarasa-Nacenta
Publikováno v:
Clinical Pharmacokinetics. 41:681-690
To evaluate the pharmacokinetic interactions between efavirenz and rifampicin (rifampin) in patients with HIV infection and tuberculosis.Nonblind, randomised, pharmacokinetic study.24 patients (21 male, 3 female; mean age 37 years) with HIV infection
Autor:
Jose M. Gatell, Luis F. López-Cortés, Marı́a Sarasa-Nacenta, Yolanda López-Púa, Josep Mallolas, Xavier Carné
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 763:53-59
Efavirenz is a non-nucleoside reverse transcriptase inhibitor for the treatment of the HIV infection. A simple, high-performance liquid chromatographic method has been developed and validated for the quantitative determination of efavirenz in human p
Autor:
Yolanda López-Púa, Xavier Carné, Josep Mallolas, Marı́a Sarasa-Nacenta, José L. Blanco, Jose M. Gatell
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 757:325-332
A rapid, simple and sensitive high-performance liquid chromatographic (HPLC) assay has been developed for the simultaneous quantification of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma. The